Aidence
Latest round
- Series A
Last raised
- Feb 2019
Total raised
- $14M
Investors
- 5
About Aidence
V.V. is based in Amsterdam, Netherlands, and specializes in AI-powered solutions for lung cancer detection. The company was co-founded by Jeroen van Duffelen and Mark-Jan Harte, with Harte currently serving as CEO., following its previous investments from Health Innovations, henQ, Inkef, Northzone, and Rabo Investments.Aidence specializes in advanced deep learning solutions aimed at enhancing lung cancer detection and care. Their core product, Veye Lung Nodules, is a CE-certified application designed for the automated detection and quantification of lung nodules in chest CT scans. This solution is seamlessly integrated into existing radiology workflows, facilitating its use in routine clinical practice and lung cancer screening programs. Veye Reporting complements this by generating clear, customizable, and shareable reports that present the findings of Veye Lung Nodules. Aidence's products are primarily utilized within the United Kingdom's National Health Service (NHS) and extend to various medical institutions across Europe that engage in lung cancer screening and diagnostics.Aidence generates revenue through a subscription-based model for its products and services, particularly focusing on B2B transactions with healthcare providers and institutions. Clients typically enter into agreements for the use of Veye Lung Nodules and Veye Reporting as part of their clinical workflows, facilitating a consistent revenue stream from ongoing subscriptions. These arrangements include tiered pricing based on the scale of deployment and the specific needs of the institution, ensuring access to the technology appropriate for their patient volume.Following the acquisition by RadNet Management, Inc.00 mn, Aidence plans to leverage its resources for expanding its footprint in the medical technology market. The strategic intent is to enhance the deployment of AI solutions to improve patient care. This will include the development of new products and features aimed at optimizing user experience and health outcomes.S. market by 2024.
Who invested in Aidence
5 investors across 2 rounds
See all investors in Aidence
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Aidence
Who invested in Aidence?
Aidence has 5 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Aidence raised?
Aidence has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Aidence last raise money?
Aidence's most recent round on record is a Series A, in Feb 2019.
What does Aidence do?
Aidence is a healthcare it company.
Where is Aidence headquartered?
Aidence is headquartered in Amsterdam, Netherlands.
Which VCs invest in companies like Aidence?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back healthcare it companies at Aidence's stage. Their profiles are linked below.
VCs backing healthcare it startups at Series A
Raising like Aidence? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.